Hantz Financial Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Hold |
0
| – | – | – | 2007 |
|
2024
Q4 | – | Sell |
-100
| Closed | -$10K | – | 1224 |
|
2024
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 797 |
|
2024
Q2 | $9K | Sell |
100
-23
| -19% | -$2.07K | ﹤0.01% | 811 |
|
2024
Q1 | $12K | Buy |
123
+60
| +95% | +$5.85K | ﹤0.01% | 813 |
|
2023
Q4 | $6K | Buy |
63
+60
| +2,000% | +$5.71K | ﹤0.01% | 895 |
|
2023
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1202 |
|
2023
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1193 |
|
2023
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1214 |
|
2022
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1172 |
|
2022
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1150 |
|